The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Adagio Therapeutics | Common Stock | 00534A102 | 4,595 | 632,855 | SH | SOLE | 632,855 | 0 | 0 | ||
Alpine Immune Sciences | Common Stock | 02083G100 | 28,110 | 2,029,580 | SH | SOLE | 2,029,580 | 0 | 0 | ||
Arcutis Biothereapeutics | Common Stock | 03969K108 | 12,938 | 623,836 | SH | SOLE | 623,836 | 0 | 0 | ||
Checkmate Pharmaceuticals | Common Stock | 162818108 | 3,832 | 1,335,050 | SH | SOLE | 1,335,050 | 0 | 0 | ||
ESSA Pharma | Common Stock | 29668H708 | 4,660 | 328,196 | SH | SOLE | 328,196 | 0 | 0 | ||
Gossamer Bio | Common Stock | 38341P102 | 35,794 | 3,164,835 | SH | SOLE | 3,164,835 | 0 | 0 | ||
Icosavax | Common Stock | 45114M109 | 9,756 | 426,395 | SH | SOLE | 426,395 | 0 | 0 | ||
Ikena Oncology | Common Stock | 45175G108 | 28,204 | 2,249,123 | SH | SOLE | 2,249,123 | 0 | 0 | ||
Imago Biosciences | Common Stock | 45250K107 | 71,574 | 3,018,737 | SH | SOLE | 3,018,737 | 0 | 0 | ||
Immunic Inc | Common Stock | 4525EP101 | 17,113 | 1,788,160 | SH | SOLE | 1,788,160 | 0 | 0 | ||
Immunocore Holdings | Common Stock | 45258D105 | 1,765 | 51,535 | SH | SOLE | 51,535 | 0 | 0 | ||
Jounce Therapeutics | Common Stock | 481116101 | 2,301 | 275,513 | SH | SOLE | 275,513 | 0 | 0 | ||
Kronos Bio | Common Stock | 50107A104 | 51,890 | 3,818,283 | SH | SOLE | 3,818,283 | 0 | 0 | ||
Morphic Holding | Common Stock | 61775R105 | 56,857 | 1,200,014 | SH | SOLE | 1,200,014 | 0 | 0 | ||
Nuvation Bio | Class A Common Stock | 67080N101 | 195,137 | 22,957,340 | SH | SOLE | 22,957,340 | 0 | 0 | ||
Omega Alpha SPAC | Class A Common Stock | G6749V107 | 4,895 | 501,000 | SH | SOLE | 501,000 | 0 | 0 | ||
Paratek Pharmaceuticals | Common Stock | 699374302 | 8,851 | 1,971,241 | SH | SOLE | 1,971,241 | 0 | 0 | ||
Replimune Group | Common Stock | 76029N106 | 129,088 | 4,763,380 | SH | SOLE | 4,763,380 | 0 | 0 | ||
Sana Biotechnology, Inc. | Common Stock | 799566104 | 13,061 | 843,750 | SH | SOLE | 843,750 | 0 | 0 | ||
Spruce Biosciences | Common Stock | 85209E109 | 9,638 | 2,161,022 | SH | SOLE | 2,161,022 | 0 | 0 | ||
Syros Pharmaceuticals | Common Stock | 87184Q107 | 8,191 | 2,512,705 | SH | SOLE | 2,512,705 | 0 | 0 | ||
Theseus Pharmaceuticals | Common Stock | 88369M101 | 9,022 | 711,479 | SH | SOLE | 711,479 | 0 | 0 |